Evidence map›Paper›PMID 25281279›Full record

ArticleBehavioural brain research2015

Repetitive grooming and sensorimotor abnormalities in an ephrin-A knockout model for Autism Spectrum Disorders.

Rachel Wurzman, Patrick A Forcelli, Christopher J Griffey, Lawrence F Kromer

Open access · greenAbstract read
In one paragraph

Article in Behavioural brain research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 67 citations in OpenAlex.

  1. The Eph-ephrin system in neuropsychiatric and neurodevelopmental disorders.Journal of psychiatry & neuroscience : JPN · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. HeterozygousHeliyon · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rachel WurzmanGeorgetown University, Department of Neuroscience, Washington, DC 20057, United States of America; Georgetown University, Interdisciplinary Program in Neuroscience, Washington, DC 20057, United States of America; Georgetown University, Department of Pharmacology and Physiology, Washington, DC 20057, United States of America. Electronic address: rpw9@georgetown.edu.
Patrick A ForcelliGeorgetown University, Interdisciplinary Program in Neuroscience, Washington, DC 20057, United States of America; Georgetown University, Department of Pharmacology and Physiology, Washington, DC 20057, United States of America.
Christopher J GriffeyGeorgetown University, Department of Biology, Washington, DC 20057, United States of America.
Lawrence F KromerGeorgetown University, Department of Neuroscience, Washington, DC 20057, United States of America; Georgetown University, Interdisciplinary Program in Neuroscience, Washington, DC 20057, United States of America.
Georgetown University · US

Funding

Predoctoral Training in Intergrative NeuroscienceT32NS041231 · NINDS · GEORGETOWN UNIVERSITY · PI Ludise Malkova, Ashley S VanMeter · 2001 to 2026
$6.8M
Heterogeneity of Synaptic NMDA ReceptorsR01NS047700 · NINDS · GEORGETOWN UNIVERSITY · PI VICINI, STEFANO · 2003 to 2011
$2.6M
A role for ephrins-A2, -A3, & -A5 in excitatory synaptic development and functionF31MH098636 · NIMH · GEORGETOWN UNIVERSITY · PI WURZMAN, RACHEL · 2012 to 2014
$74k
NIMH NIH HHS F31 MH098636NINDS NIH HHS R01 NS047700NINDS NIH HHS T32 NS041231
6 · The paper itself

Abstract

EphA receptors and ephrin-A ligands play important roles in neural development and synaptic plasticity in brain regions where expression persists into adulthood. Recently, EPHA3 and EPHA7 gene mutations were linked with Autism Spectrum Disorders (ASDs) and developmental neurological delays, respectively. Furthermore, deletions of ephrin-A2 or ephrin-A3, which exhibit high binding affinity for EphA3 and EphA7 receptors, are associated with subtle deficits in learning and memory behavior and abnormalities in dendritic spine morphology in the cortex and hippocampus in mice. To better characterize a potential role for these ligands in ASDs, we performed a comprehensive behavioral characterization of anxiety-like, sensorimotor, learning, and social behaviors in ephrin-A2/-A3 double knockout (DKO) mice. The predominant phenotype in DKO mice was repetitive and self-injurious grooming behaviors such as have been associated with corticostriatal circuit abnormalities in other rodent models of neuropsychiatric disorders. Consistent with ASDs specifically, DKO mice exhibited decreased preference for social interaction in the social approach assay, decreased locomotor activity in the open field, increased prepulse inhibition of acoustic startle, and a shift towards self-directed activity (e.g., grooming) in novel environments, such as marble burying. Although there were no gross deficits in cognitive assays, subtle differences in performance on fear conditioning and in the Morris water maze resembled traits observed in other rodent models of ASD. We therefore conclude that ephrin-A2/-A3 DKO mice have utility as a novel ASD model with an emphasis on sensory abnormalities and restricted, repetitive behavioral symptoms.

Indexed as

AnimalsAutism Spectrum DisorderConditioning, PsychologicalDisease Models, AnimalEphrin-A2Ephrin-A3Exploratory BehaviorFearGait Disorders, NeurologicGroomingInterpersonal RelationsMaze LearningMiceMice, Inbred C57BLMice, TransgenicMotor ActivityEphrin-A2Ephrin-A3ASD mouse modelAutism spectrum disorderBehaviorEphrin-AGrooming

Identifiers

PMID25281279
PMCPMC4382445
OpenAlexW1988915278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.